🩺

Medically reviewed by the Vital Signs Today Medical Review Board. Last updated 18 June 2026. Every range and figure below is drawn from the peer-reviewed and clinical sources listed at the end of this article.
Key takeaways

  • A PSA below 4.0 ng/mL has long been treated as the general cutoff in men, but the National Cancer Institute notes there is no single normal PSA level, and many clinicians now adjust the threshold up or down by age.
  • Age-specific PSA reference ranges commonly used in practice are 0.0 to 2.5 ng/mL for ages 40 to 49, 0.0 to 3.5 ng/mL for 50 to 59, 0.0 to 4.5 ng/mL for 60 to 69, and 0.0 to 6.5 ng/mL for 70 to 79 (Oesterling reference ranges).
  • Women do not have a prostate, so PSA in female blood is normally very low or undetectable, roughly 1,000 times lower than in men, and the PSA blood test is not used as a routine screening tool in women.

What is a normal PSA level?

There is no single normal PSA level. The National Cancer Institute states plainly that there is “no specific normal or abnormal level of PSA in the blood.” Historically, a value below 4.0 ng/mL was treated as normal, and a result above 4.0 ng/mL could trigger more testing such as a prostate biopsy (Cleveland Clinic; NCI). Modern practice reads the number in context rather than against one fixed line.

PSA, or prostate-specific antigen, is a protein made by the prostate gland and measured in nanograms per milliliter of blood (ng/mL). Because the prostate enlarges naturally with age, PSA tends to creep up over the years even in men with no cancer (Cleveland Clinic). That is why your age, prostate size, recent results, and symptoms all shape how a given number is interpreted. A 0.8 ng/mL in a 45-year-old and a 0.8 ng/mL in a 75-year-old carry different meaning, and a rising trend over time can matter more than any single reading.

Want to check PSA yourself?

Test your PSA from home with an Everlywell at-home kit, processed by a CLIA-certified lab.

See the at-home test →

PSA normal range by age

The most widely cited age-specific PSA reference ranges rise step by step with each decade: 0.0 to 2.5 ng/mL for men in their 40s and up to 0.0 to 6.5 ng/mL for men in their 70s (Oesterling age-specific reference ranges, summarized by CancerNetwork). These ranges were designed to catch more early cancers in younger men and reduce false alarms in older men.

Age group Sex Age-specific PSA reference range
40 to 49 Male 0.0 to 2.5 ng/mL
50 to 59 Male 0.0 to 3.5 ng/mL
60 to 69 Male 0.0 to 4.5 ng/mL
70 to 79 Male 0.0 to 6.5 ng/mL
Any adult age Female Normally very low or undetectable (about 1,000x lower than men); not used for routine screening

How to read the table: these are reference ranges, not pass-fail grades. A result inside the range does not guarantee a healthy prostate, and a result slightly above it does not confirm cancer. Some clinicians still anchor on the traditional 4.0 ng/mL line and use age only as a tiebreaker (NCI). Always pair the number with your own history.

How does sex change the range?

Sex changes the range dramatically because only the prostate makes significant PSA. Women have no prostate, so PSA in female blood is normally very low or undetectable, at concentrations roughly 1,000 times lower than in men (PubMed review of PSA in women). The PSA blood test is therefore a male-focused tool and is not used as a routine screening test in women.

Small amounts of PSA can still appear in women because the protein is also produced in some hormonally regulated tissues, principally the breast (PubMed). In one large analysis, about 83% of women had no detectable serum PSA at all, and most of the rest sat in a tiny band well under 0.05 ng/mL. Researchers continue to study whether ultra-sensitive PSA assays could one day help flag certain breast or other tumors in women, but that is research, not standard care. For practical purposes, if you are a woman and a lab reports a PSA value, discuss with your clinician what test was run and why, because this is uncommon outside of specialized study settings.

What makes PSA rise or fall with age?

PSA tends to rise with age mainly because the prostate gland enlarges over time, a process so common that age-specific ranges build it in, climbing from 2.5 ng/mL in the 40s to 6.5 ng/mL in the 70s (Oesterling ranges via CancerNetwork). Age is the single biggest driver of a gently rising baseline.

Several non-cancer factors also move the number, and knowing them helps you avoid false alarms:

  • Benign prostatic hyperplasia (BPH): age-related, non-cancerous prostate enlargement that raises PSA (Cleveland Clinic).
  • Prostatitis or urinary infection: inflammation can push PSA up temporarily.
  • Recent activity: ejaculation, a digital rectal exam, cycling, or a recent catheter can nudge readings higher.
  • Medications: certain drugs for BPH or hair loss (5-alpha-reductase inhibitors like finasteride) can roughly halve PSA, so the lab number may understate the true value.

Because of these swings, a single high reading is often repeated before any decision. Your clinician may also track PSA velocity, which is how fast the number changes over time, since a steady climb can be more telling than one isolated value.

When is an out-of-range result a concern?

An out-of-range PSA is a signal to investigate, not a diagnosis. A value between 4 and 10 ng/mL carries roughly a 25% chance of prostate cancer, and a value of 10 ng/mL or higher signals a substantially greater risk (Cleveland Clinic; NCI). The 4 to 10 band is often called the diagnostic gray zone because many men in it have benign enlargement rather than cancer.

What usually happens next depends on the full picture. Your clinician may repeat the test, check the percent free PSA (a lower free fraction leans more toward cancer), order imaging such as an MRI, or recommend a biopsy. Symptoms matter too: trouble urinating, blood in urine or semen, or pelvic discomfort raise the priority of a workup. On the other hand, a recently elevated reading after cycling, infection, or ejaculation may simply be repeated after a pause. The goal is to separate a real, sustained rise from a temporary blip, then decide together whether further testing is worth it for you.

If your PSA is climbing steadily over several tests, even within the normal range, mention it. Trend often outweighs a single snapshot.

Related reading

Frequently asked questions

Is a PSA of 4.0 ng/mL high?

4.0 ng/mL sits at the traditional cutoff. The National Cancer Institute notes there is no fixed normal level, but a result above 4.0 ng/mL has historically prompted more testing. Whether it is concerning for you depends on your age, trend, and symptoms, so discuss it with your clinician.

What is a normal PSA for a 70-year-old man?

A common age-specific reference range for men 70 to 79 is 0.0 to 6.5 ng/mL (Oesterling ranges). PSA naturally rises with age as the prostate enlarges, so a reading that would be high at 45 may be expected at 75. Your own baseline and trend still matter most.

Do women have a PSA level?

Women have no prostate, so PSA in female blood is normally very low or undetectable, roughly 1,000 times lower than in men. Tiny amounts can come from breast tissue. The PSA blood test is not used as a routine screening tool in women.

Can a high PSA be something other than cancer?

Yes. Benign prostatic hyperplasia, prostatitis, a urinary infection, a recent digital rectal exam, ejaculation, or vigorous cycling can all raise PSA without cancer being present (Cleveland Clinic). That is why a single high reading is often repeated before any further steps.

What PSA level requires a biopsy?

There is no automatic biopsy number. A PSA between 4 and 10 ng/mL carries about a 25% cancer risk, and 10 ng/mL or higher raises it further (Cleveland Clinic). Clinicians weigh age, free PSA, MRI findings, and symptoms before recommending a biopsy.

Sources

This article is for general educational purposes and is not medical advice. It cannot diagnose or treat you and does not replace your clinician. Always discuss your lab results and any health decisions with a qualified healthcare professional.